» Articles » PMID: 36013453

The Insulin-like Growth Factor System and Colorectal Cancer

Overview
Journal Life (Basel)
Specialty Biology
Date 2022 Aug 26
PMID 36013453
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin-like growth factors (IGFs) are peptides which exert mitogenic, endocrine and cytokine activities. Together with their receptors, binding proteins and associated molecules, they participate in numerous pathophysiological processes, including cancer development. Colorectal cancer (CRC) is a disease with high incidence and mortality rates worldwide, whose etiology usually represents a combination of the environmental and genetic factors. IGFs are most often increased in CRC, enabling excessive autocrine/paracrine stimulation of the cell growth. Overexpression or increased activation/accessibility of IGF receptors is a coinciding step which transmits IGF-related signals. A number of molecules and biochemical mechanisms exert modulatory effects shaping the final outcome of the IGF-stimulated processes, frequently leading to neoplastic transformation in the case of irreparable disbalance. The IGF system and related molecules and pathways which participate in the development of CRC are the focus of this review.

Citing Articles

The expression of exosomal and cellular miRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in silico and in vitro study.

Deli H, Vakili-Ghartavol Z, Asgari Y, Tavoosidana G, Eftekhar E, Ghahremani M BMC Cancer. 2025; 25(1):46.

PMID: 39789474 PMC: 11715296. DOI: 10.1186/s12885-024-13392-2.


LncRNAs Involved in Antioxidant Response Regulation as Biomarkers of Gestational Diabetes: A Study on , and .

Stevanovic J, Petrovic U, Penezic A, Radojicic O, Ardalic D, Mandic M Antioxidants (Basel). 2025; 13(12.

PMID: 39765830 PMC: 11673377. DOI: 10.3390/antiox13121503.


Biomarkers of lymph node metastasis in colorectal cancer: update.

Zhu X, Lin S, Xie J, Wang L, Zhang L, Xu L Front Oncol. 2024; 14:1409627.

PMID: 39328205 PMC: 11424378. DOI: 10.3389/fonc.2024.1409627.


The Role of Adipocytes Recruited as Part of Tumor Microenvironment in Promoting Colorectal Cancer Metastases.

Ma Y, Nenkov M, Chen Y, Gassler N Int J Mol Sci. 2024; 25(15).

PMID: 39125923 PMC: 11313311. DOI: 10.3390/ijms25158352.


Supplementation during Early Life Alters Gut Microbiota and Inhibits Young-Onset Intestinal Tumorigenesis in Mice Later in Life.

Lin T, Daddi L, Tang Y, Zhou Y, Liu B, Moore M Nutrients. 2024; 16(15).

PMID: 39125288 PMC: 11314251. DOI: 10.3390/nu16152408.


References
1.
Mancarella C, Scotlandi K . IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives. Front Cell Dev Biol. 2020; 7:363. PMC: 6974587. DOI: 10.3389/fcell.2019.00363. View

2.
Zhang Q, Wang L, Song Z, Qu X . Knockdown of type I insulin-like growth factor receptor inhibits human colorectal cancer cell growth and downstream PI3K/Akt, WNT/β-catenin signal pathways. Biomed Pharmacother. 2015; 73:12-8. DOI: 10.1016/j.biopha.2015.05.004. View

3.
Ma X, Wang S, Ye Y, Du R, Cui Z, Somsouk M . Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroenterol. 2004; 10(11):1569-73. PMC: 4572756. DOI: 10.3748/wjg.v10.i11.1569. View

4.
Philippou A, Christopoulos P, Koutsilieris D . Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer. Mutat Res Rev Mutat Res. 2017; 772:105-122. DOI: 10.1016/j.mrrev.2016.09.005. View

5.
Austin H, Henley S, King J, Richardson L, Eheman C . Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening. Cancer Causes Control. 2013; 25(2):191-201. PMC: 4394895. DOI: 10.1007/s10552-013-0321-y. View